Bulk Manufacturer of Controlled Substances Application: Euticals Inc., 50159 [2017-23556]
Download as PDF
<![CDATA[
50159
Federal Register / Vol. 82, No. 208 / Monday, October 30, 2017 / Notices
Co., Limited, No. 3 Xia Yuan Road,
Dong Ji, Industrial District, Getdd,
Guangzhou 510730, China.
(3) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
The Office of Unfair Import
Investigations will not participate as a
party in the investigation.
The Commission notes that issues
regarding whether the importation
requirement of section 337 is met may
be present here. In instituting this
investigation, the Commission has not
made any determination as to whether
Complainant has satisfied this
requirement. Accordingly, the presiding
Administrative Law Judge may wish to
consider this issue at an early date.
Notwithstanding any Commission Rules
to the contrary, which are hereby
waived, any such decision should be
issued in the form of an initial
determination (ID) under Rule 210.42(c),
19 CFR 210.42(c). The ID will become
the Commission’s final determination
45 days after the date of service of the
ID unless the Commission determines to
review the ID. Any such review will be
conducted in accordance with
Commission Rules 210.43, 210.44, and
210.45, 19 CFR 210.43, 210.44, and
210.45.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), such
responses will be considered by the
Commission if received not later than 20
days after the date of service by the
Commission of the complaint and the
notice of investigation. Extensions of
time for submitting responses to the
complaint and the notice of
investigation will not be granted unless
good cause therefor is shown.
Failure of a respondent to file a timely
response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: October 25, 2017.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2017–23542 Filed 10–27–17; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Euticals Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 29, 2017.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. Comments and requests for
hearings on applications to import raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on June
20, 2017, Euticals, Inc., 2460 W. Bennett
Street, Springfield, Missouri 65807–
1229 applied to be registered as a bulk
manufacturer the following basic classes
of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Amphetamine ...................................................................................................................................................................
Lisdexamfetamine ............................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Phenylacetone .................................................................................................................................................................
Methadone .......................................................................................................................................................................
Methadone intermediate ..................................................................................................................................................
Tapentadol .......................................................................................................................................................................
sradovich on DSK3GMQ082PROD with NOTICES
The company plans to manufacture
the listed controlled substances in bulk
for distribution and sale to its
customers.
[OMB Number 1110–0049]
Agency Information Collection
Activities; Proposed eCollection;
eComments Requested InfraGard
Membership Application and Profile
Dated: October 17, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017–23556 Filed 10–27–17; 8:45 am]
Federal Bureau of
Investigation, Department of Justice.
AGENCY:
BILLING CODE 4410–09–P
ACTION:
VerDate Sep<11>2014
17:59 Oct 27, 2017
Jkt 244001
PO 00000
30-day notice.
Frm 00044
Fmt 4703
Sfmt 4703
I
II
II
II
II
II
II
II
Department of Justice (DOJ),
Federal Bureau of Investigation (FBI),
Training Division’s Curriculum
Management Section (CMS) will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
This proposed information collection
was previously published in the Federal
Register, on August 3, 2017 allowing for
a 60 day comment period.
SUMMARY:
DEPARTMENT OF JUSTICE
2010
1100
1205
1724
8501
9250
9254
9780
Schedule
E:\FR\FM\30OCN1.SGM
30OCN1
]]>Agencies
[Federal Register Volume 82, Number 208 (Monday, October 30, 2017)]
[Notices]
[Page 50159]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-23556]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Euticals
Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before December 29, 2017.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152. Comments and
requests for hearings on applications to import raw material are not
appropriate. 72 FR 3417 (January 25, 2007).
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on June
20, 2017, Euticals, Inc., 2460 W. Bennett Street, Springfield, Missouri
65807-1229 applied to be registered as a bulk manufacturer the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid................ 2010 I
Amphetamine.............................. 1100 II
Lisdexamfetamine......................... 1205 II
Methylphenidate.......................... 1724 II
Phenylacetone............................ 8501 II
Methadone................................ 9250 II
Methadone intermediate................... 9254 II
Tapentadol............................... 9780 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution and sale to its customers.
Dated: October 17, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-23556 Filed 10-27-17; 8:45 am]
BILLING CODE 4410-09-P
